Opko Health (OPK) Net Equity Issued and Repurchased (2010 - 2022)

Opko Health (OPK) has 13 years of Net Equity Issued and Repurchased data on file, last reported at -$135000.0 in Q2 2022.

• Quarterly Net Equity Issued and Repurchased rose 56.17% year-over-year to -$135000.0 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $1.1 million (changed N/A YoY) and the FY2023 annual result came in at -$272000.0, up 64.86% from the prior year.
• Net Equity Issued and Repurchased slipped to -$135000.0 in Q2 2022, from $136000.0 in the prior quarter.
• In the past five years, Net Equity Issued and Repurchased ranged from a high of $91.3 million in Q4 2018 to a low of -$669000.0 in Q4 2020.
• A 5-year average of $13.0 million and a median of $308000.0 in 2021 frame the typical range for Net Equity Issued and Repurchased.
• Annual changes were most pronounced in 2018 — Net Equity Issued and Repurchased surged 4866.54% — and 2020, when it plunged 100.88%.
• Tracing OPK's Net Equity Issued and Repurchased over 5 years: stood at $91.3 million in 2018, then declined by 16.71% to $76.1 million in 2019, then plunged by 100.88% to -$669000.0 in 2020, then jumped by 130.04% to $201000.0 in 2021, then tumbled by 167.16% to -$135000.0 in 2022.
• The last three Net Equity Issued and Repurchased figures came in at -$135000.0 (Q2 2022), $136000.0 (Q1 2022), and $201000.0 (Q4 2021), per Business Quant data.